tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
LENZ
LENZ Therapeutics
RESEARCH TOOLSreports

LENZ Therapeutics (LENZ) Stock News & Sentiment

379 Followers
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
Premium
Company Announcements
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
12d ago
LENZ
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
Premium
Ratings
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
15d ago
LENZ
Is LENZ a Buy, Before Earnings?
Premium
Pre-Earnings
Is LENZ a Buy, Before Earnings?
18d ago
LENZ
LENZ Therapeutics: Early VIZZ Launch, Targeted DTC Campaign, and Differentiated Presbyopia Profile Underpin Buy Rating
Premium
Ratings
LENZ Therapeutics: Early VIZZ Launch, Targeted DTC Campaign, and Differentiated Presbyopia Profile Underpin Buy Rating
3M ago
LENZ
Robust Early Adoption, Favorable Safety Profile, and Upcoming DTC Campaign Support Buy Rating on VIZZ
Premium
Ratings
Robust Early Adoption, Favorable Safety Profile, and Upcoming DTC Campaign Support Buy Rating on VIZZ
3M ago
LENZ
Overreaction to LENZ Therapeutics’ Stock Decline Presents Buying Opportunity Despite Isolated Retinal Tear Incident
Premium
Ratings
Overreaction to LENZ Therapeutics’ Stock Decline Presents Buying Opportunity Despite Isolated Retinal Tear Incident
4M ago
LENZ
LENZ Therapeutics: Buy Rating Affirmed Amid Overreaction to Isolated Adverse Event
Premium
Ratings
LENZ Therapeutics: Buy Rating Affirmed Amid Overreaction to Isolated Adverse Event
4M ago
LENZ
More LENZ News >

LENZ News on the Web

LENZ Therapeutics Insiders Go on a Buying Spree, Signaling Big Confidence Ahead
TipRanks News
Neutral
Insider Buying: Jeffrey George Acquires Shares of LENZ Therapeutics Inc (LENZ)
GuruFocus News
Neutral
Lenz Therapeutics Earnings Call: High Spend, Growing Traction
TipRanks News
Bullish
Lenz Therapeutics price target lowered to $26 from $52 at Citi
TipRanks News
Bearish
Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), LENZ Therapeutics (LENZ) and Sarepta Therapeutics (SRPT)
TipRanks News
Bullish
Buy Rating on VIZZ Underscored by Improving Prescription Trends and Long-Term Upside Despite Near-Term Revenue Revisions
TipRanks News
Bullish
Lenz Therapeutics price target lowered to $29 from $35 at BofA
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and LENZ Therapeutics (LENZ)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LENZ’s Media Buzz Sentiment?
Currently, no data Available
What is LENZ’s weekly average amount of articles?
Currently, no data Available
What is LENZ’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NBIXNeurocrine
STAAStaar Surgical
AORTArtivion
OWLTOwlet
HUMHumana
Showing the stocks with the most bullish news sentiment over the past week